pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
globenewswire health·1d ago·1 min read
save

Vaisala senior manager Vesa Pylvänäinen disposes 1,582 shares at €56.92 each

Jul 27, 2026·read at globenewswire health ↗Neutral

Vaisala Corporation disclosed that senior manager Vesa Pylvänäinen sold a portion of his holdings.

The disposal involved 1,582 shares of Vaisala A shares, with a volume‑weighted average price of €56.92 per share.

The transaction was executed on the Nasdaq Helsinki exchange on July 23, 2026 and reported as an initial notification.

Vaisala noted that its shares continue to trade on Nasdaq Helsinki and provided investor‑relations contact details for further inquiries.

source

This writeup was produced by pharmadog from original reporting by globenewswire health.

Original headline: “Vaisala Corporation: Managers’ Transactions – Pylvänäinen, Vesa”

read at globenewswire health ↗
177 words · retrieved 5h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 21h agoDSV, 1172 - MANAGER'S TRANSACTIONS IN DSV A/S SHARESglobenewswire health
  • 23h agoOKYO Pharma Announces Purchase of Shares by Chief Scientific Officerglobenewswire health
  • 1d agoDanske Bank A/S, ledende medarbejderes transaktionerglobenewswire health
  • 1d agoDanske Bank A/S, transactions by persons discharging managerial responsibilitiesglobenewswire health
  • 1d agoVaisala Oyj: Johtohenkilöiden liiketoimet – Pylvänäinen, Vesaglobenewswire health